Benfluorex

This classification denotes an anti-lipidemic agent and anorexiant with the molecular formula C19H20F3NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 403FO0NQG3, chemically known as phenethylamine, n-(2-hydroxyethyl)-alpha-methyl-m-trifluoromethyl-, benzoate but more generally known as benfluorex, which bears US NIH Compound Identifier 2318. Benfluorex most often comes in base and hydrochloride forms. European Medicines Agency schedules Benfluorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05714MIG. The term BENFLUOREX is an International Non-Proprietary Name WHO schedules benfluorex in its Anatomical Therapeutic Chemical (ATC) Classification. BENFLUOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benfluorex under HS 29221980 and SITC 51461. As of Q4 2014, BENFLUOREX remains US FDA's Preferred Term for this commodity. Benfluorex bears US NLM identifiers UMLS ID C0053105 and NCI Concept Code C72936. SMILES: FC(F)(F)C1CC(CC(NCCOC(=O)C2CCCCC2)C)CCC1.